PREMII Trademark

Trademark Overview

On Tuesday, July 24, 2018, a trademark application was filed for PREMII with the United States Patent and Trademark Office. The USPTO has given the PREMII trademark a serial number of 88050386. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2019. This trademark is owned by Shire Human Genetic Therapies, Inc.. The PREMII trademark is filed in the Paper & Printed Material Products category with the following description:

Questionnaires on health for use by medical professionals to assess the needs of premature infants
premii

General Information

Serial Number88050386
Word MarkPREMII
Filing DateTuesday, July 24, 2018
Status700 - REGISTERED
Status DateTuesday, July 30, 2019
Registration Number5823582
Registration DateTuesday, July 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesQuestionnaires on health for use by medical professionals to assess the needs of premature infants
Pseudo MarkPREMATURE
Translation of Words in MarkThe English translation of "PREMII" in the mark is "REWARDS".

Classification Information

International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateSaturday, July 28, 2018
Primary Code016
First Use Anywhere DateTuesday, February 28, 2017
First Use In Commerce DateTuesday, February 28, 2017

Trademark Owner History

Party NameShire Human Genetic Therapies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameShire Human Genetic Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Saturday, November 17, 2018NON-FINAL ACTION WRITTEN
Friday, July 27, 2018NEW APPLICATION ENTERED
Saturday, July 28, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 9, 2018ASSIGNED TO EXAMINER
Saturday, November 17, 2018NON-FINAL ACTION E-MAILED
Saturday, November 17, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 19, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2019ASSIGNED TO LIE
Friday, April 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 27, 2019TEAS AMENDMENT OF USE RECEIVED
Monday, April 29, 2019USE AMENDMENT FILED
Monday, April 29, 2019AMENDMENT TO USE PROCESSING COMPLETE
Monday, May 20, 2019USE AMENDMENT ACCEPTED
Monday, May 20, 2019FINAL REFUSAL WRITTEN
Monday, May 20, 2019FINAL REFUSAL E-MAILED
Monday, May 20, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, May 21, 2019NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, June 20, 2019ASSIGNED TO LIE
Wednesday, June 26, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, June 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, June 2, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, June 15, 2019APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, July 30, 2019REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

premii needs premature infants assess professionals health medical questionnaires